Abbott

Sanofi and Abbott in Diabetes Management Pact

Bioelectronic Medicines: A New Type of Personalization

Johnson & Johnson Buys Abbott’s Eye Unit

Mylan to Buy Sweden’s Meda for $9.9 Billion

Recipharm Appoints Chief Strategy Officer

Mylan Said to Prepare Poison Pill Potion Against Teva

Mylan Trims Forecast Due to FDA Approval Delays

AbbVie Wins Shire Prize for Nearly $55 Billion

Mylan to Pay Abbott $5.3 Billion for Non-US Business

The Biosimilar Market

iBIO and iBIO Institute Boards Elect Andy Hull and Linda Friedman as 2014 Chairs

Carlyle Said Close to Buying J&J Diagnostics Unit

Bayer Divestment of its MaterialScience Unit ‘Inevitable,’ Analysts Say

China Blocks GSK Finance Head From Leaving Country

Abbott to Buy OptiMedica, Strengthens Medical Device Focus

Getting The Pulse

The Lion City - The Merlion - a mythical creature with the head of a lion and the body of a fish - is regarded as the Singapore icon ("Singapura" means "lion city" in Sanskrit). As one of the world's leading energy and chemical hubs, Singapore's contribution to the chemical industry is vast, both in terms of output and research.

After Tech Success, Israel Seeks Life Sciences Growth

Drug Industry CEOs Plotting More Carve-outs

AbbVie Delivers on Scorching Humira Drug Sales Growth

Abbott Devices, Generics Struggle

GlaxoSmithKline Unit Joins Patent Pool for AIDS Drugs

AbbVie Forecasts Slower Humira Growth

Abbott Results Bode Well for Spun-off AbbVie

Medtech Companies Face Job Cuts

Abbott Board Paves Way for Split of Company

Abbott Q3 Profit Tops View

FTC Takes "Pay for Delay" Drug Case to U.S. Supreme Court

U.S. Judge Approves $700 Million in Abbott Depakote Fines

Abbott Misstated Credentials of Spinoff CEO Gonzalez

Implant Scandal Sparks EU Medical Device Rule Revamp

The Pharmaceutical Supply Chain

Abbott Sticks to 2012 View, Despite Stronger Dollar

India to Give Free Generic Drugs to Hundreds of Millions

US Top Court Rules for Glaxo on Overtime Pay

Abbott Lifts 2012 Forecast